Anti-Ro52/TRIM21 seropositivity in interstitial lung disease: effect modification by disease subtype and myositis-specific antibody context
Anti-Ro52/TRIM21 shows contradictory prognostic associations in interstitial lung disease (ILD), protective in some cohorts and adverse in others. We evaluated whether it acts as an independent predictor or a phenotypic marker and whether its effect is modified by disease subtype and myositis-specific antibodies....